Successful long-term control of lanadelumab-refractory type 2 hereditary angioedema with berotralstat
Type 2 hereditary angioedema (HAE-C1INH-Type2) is a rare, potentially life-threatening disorder characterized by functional impairment of C1-esterase inhibitor (C1-INH). Responses to long-term prophylactic (LTP) therapies are variable. We describe a case of HAE-C1INH-Type2 refractory to tranexamic acid, danazol, C1-INH...